Devyser wins breakthrough contract in Canada for non-invasive fetal RHD testing

STOCKHOLM, June 22, 2022 /PRNewswire/ — Devyser has been awarded a tender from Héma-Québec, in Québec, Canada, for its non-invasive fetal RHD detection product, used to determine fetal RHD status from maternal plasma in early pregnancy. The tender is initially valid over three years…